Join this session to learn how surgical innovation is advancing the comprehensive management of atrial fibrillation; highlighting breakthrough technologies, evolving clinical evidence, and the expanding role of left atrial appendage closure. This session will examine how these developments are driving more integrated treatment strategies and shaping the future of rhythm management within cardiac surgery.
Hall 2 60 TRANSPARENTSession description
Join this session as we collectively explore how the surgical management of atrial fibrillation (AF) could evolve by 2026 — from optimized ablation techniques to effective and secure closure of the left atrial appendage (LAA).
We will examine how recent innovations and clinical data are driving a more coordinated approach to AF treatment within cardiac surgery. This session will foster expert dialogue around procedural efficiency, safety, and long-term patient outcomes.
| Time | Topic | Faculty |
|---|---|---|
|
12:15 |
Welcome |
Miss Evans |
|
12:18 |
Atrial Fibrillation in 2026: Evolving Guidelines, Practices, and Expectations |
Dr Carnero |
|
12:35 |
Looking Back to Move Forward |
Prof Choi |
|
12:50 |
Redefining Surgical LAA Closure |
Prof Sternik |
|
13: 05 |
The BOX: From Surgical Practice to Clinical Evidence |
Prof Roussel |
|
13:20 |
Conclusion and final remarks |
Miss Evans |